Table 2 Distribution of the three MTHFR C677T genotypes in patients with poor efficacy
Patients with poor efficacy | CC (n = 1) | TT (n = 49) | CT (n = 9) |
|---|---|---|---|
Decrease< 20% (n = 47) | 1 | 38 | 8 |
Unstable increase (n = 12) | 0 | 11 | 1 |
Patients with poor efficacy | CC (n = 1) | TT (n = 49) | CT (n = 9) |
|---|---|---|---|
Decrease< 20% (n = 47) | 1 | 38 | 8 |
Unstable increase (n = 12) | 0 | 11 | 1 |